Hypopituitarism - Thomas
Hypopituitarism - Thomas
Hypopituitarism - Thomas
8% unknown
1% sarcoidosis
Characterized by
low LH and FSH levels
low concentrations of sex steroids
Males patients
Delayed puberty and hypogonadism, including micropenis
Long-term treatment:
human chorionic gonadotropin (hCG) or testosterone
Female patients
Primary amenorrhea and failure of secondary sexual
development
Long-term treatment:
cyclic estrogen and progestin
Cranial irradiation
Lymphocytic hypophysitis
Pituitary Apoplexy
Incidence: 3.6%
Of 25 cases studied:
Pituitary
masses may undergo clinically silent infarction
with development of a partial or totally empty sella by
cerebrospinal fluid (CSF) filling the dural herniation.
Age at onset
Speed of onset
Pale complexion
Unable to tan or maintain a tan
May complain of
Fatigue
Degrees exercise tolerance
Abdominal obesity
Loss of muscle mass
Children
GH Deficiency
ACTH reserve
Metyrapone test (750 mg q 4hr for 24 hrs)
Cortisol < 7 μg/dL, 11-deoxycortisol > 10 μg/dL
ITT ( 0.1 U/kg BW)
Cortisol > 18 μg/dL, normal
Cosyntropin stimulation test
Cortisol > 18 μg/dL, normal
Serum T4 should be measured
Sperm count
WOMEN
LH-FSH,
E2, vaginal cytology, response to
medroxyprogesterone 10 mg qd for 10 days
Peak GH response < 5 ng/ml
ITT
Growth hormone
Vasopressin (desmopressin 10 μg x 2)
Hormone replacement therapy